Reported Aug 13, 2014 · Terminated
Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by
Novartis Pharmaceuticals Corp.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Novartis Pharmaceuticals Corp. · 25 Old Mill Rd · Suffern, NY · 10901-4106
Is this the product you have?
Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by
3 of 3 products
| # | Product as published |
|---|---|
| 1 | Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5 |
| 2 | Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey 07936 |
| 3 | NDC 0078-0436-05, UPC 3 0078-0436-05 2. |
- Lot codes and dates
- Lot # PKTS, Exp 01/17
- Amount recalled
- 50 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Novartis Pharmaceuticals Corp. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.